“Preclinical Use of Group I Metabotropic Glutamate Receptors (Group I mGluRs) for Ischemic Stroke: Systematic Review and Meta-Analysis” (2025) American Journal of Medical Science and Innovation, 4(2), pp. 118–126. doi:10.54536/ajmsi.v4i2.6056.